Clinical trials sponsored by Abramson Cancer Center at Penn Medicine

Phase breakdown

Conditions studied

Recruiting trials led by Abramson Cancer Center at Penn Medicine

• A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
  NCT07655934 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials
  NCT07040891 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
  NCT04523857 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CTNNA1 Familial Expansion Study
  NCT05126290 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
  NCT04332367 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Collection of Circulating Biomarkers in Pancreatic Cancer
  NCT05743049 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
  NCT07454499 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• FTT PET/CT in Pancreatic Neuroendocrine Tumors
  NCT07114939 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Hypofractionated WPPT With HDR Boost
  NCT06591819 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
  NCT06578637 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Low Dose Radiotherapy for Osteoarthritis
  NCT07715188 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
  NCT06747845 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
  NCT02478892 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prostate Tissue BioBank
  NCT06659614 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
  NCT06551116 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer
  NCT03546829 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Telehealth Collaborative Care Model (CoCM) in Lung Cancer
  NCT07102147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
  NCT04691817 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• [18F] F-GLN by PET/CT in Breast Cancer
  NCT03863457 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Abramson Cancer Center at Penn Medicine recruiting for?

Abramson Cancer Center at Penn Medicine is the lead sponsor of 19 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.